Treatment of hypertension with ascorbic acid.
In a randomised, double-blind, placebo-controlled study we showed that treatment of hypertensive patients with ascorbic acid lowers blood pressure. Further studies of ascorbic acid to treat hypertension, with clinical endpoints, are warranted.
| Publicado en: | Lancet Vol. 354; no. 9195; pp. 2048 - 2050 |
|---|---|
| Autores principales: | , , , , , , , , , , , , , |
| Formato: | letter research randomized controlled trial Journal Article |
| Publicado: |
Lancet
12/11/1999
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=2585332&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 2585332 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 01406736 LAN jtl: Lancet issn: 01406736 maglogo: N pubinfo: dt: 12/11/1999 vid: 354 iid: 9195 pid: 1297 pub: Lancet place: Philadelphia, Pennsylvania artinfo: ui: 2585332 2585332 NLM10636373 2585332 10.1016/S0140-6736(99)04410-4 NLM10636373 2585332 ppf: 2048 ppct: 2 formats: fmt: @attributes: type: P tig: atl: Treatment of hypertension with ascorbic acid. aug: au: Duffy, Stephen J. Gokce, Noyan Holbrook, Monika Huang, Annong Frei, Balz Keaney Jr., John F. Vita, Joseph A. Duffy, S J Gokce, N Holbrook, M Huang, A Frei, B Keaney, J F Jr Vita, J A sug: subj: Ascorbic Acid Administration and Dosage Hypertension Drug Therapy Treatment Outcomes Aged Female Hypertension Etiology Middle Age Double-Blind Studies Male Human Reactive Oxygen Species Metabolism Blood Pressure Drug Effects Ascorbic Acid Adverse Effects Adult Clinical Trials Validation Studies Comparative Studies Evaluation Research Multicenter Studies Randomized Controlled Trials Scales Aged: 65+ years Middle Aged: 45-64 years Adult: 19-44 years Female Male ab: In a randomised, double-blind, placebo-controlled study we showed that treatment of hypertensive patients with ascorbic acid lowers blood pressure. Further studies of ascorbic acid to treat hypertension, with clinical endpoints, are warranted. pubtype: Academic Journal doctype: letter research randomized controlled trial Journal Article ougenre: Unknown language: English refInfo: holdings: @attributes: islocal: N |
|---|